168 related articles for article (PubMed ID: 6468676)
1. Antispermatogenic action of gossypol in men.
Coutinho EM; Melo JF; Barbosa I; Segal SJ
Fertil Steril; 1984 Sep; 42(3):424-30. PubMed ID: 6468676
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with gossypol in non-Chinese men: a follow-up.
Coutinho EM; Melo JF
Contraception; 1988 Feb; 37(2):137-51. PubMed ID: 3286112
[TBL] [Abstract][Full Text] [Related]
3. Relationship between hormone profiles and the restoration of spermatogenesis in men treated with gossypol.
Gu ZP; Wang YX; Sang GW; Wang WC; Chen ZX; Zhao XJ; Shao QX; Jiang Y
Int J Androl; 1990 Aug; 13(4):253-7. PubMed ID: 2117586
[TBL] [Abstract][Full Text] [Related]
4. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Guerin JF; Rollet J
Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
[TBL] [Abstract][Full Text] [Related]
6. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
7. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
8. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men.
Foegh M; Nicol K; Petersen IB; Schou G
Contraception; 1980 Jun; 21(6):631-40. PubMed ID: 6775869
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
11. Gossypol-induced hypokalemia and role of exogenous potassium salt supplementation when used as an antispermatogenic agent in male langur monkey.
Kumar M; Sharma S; Lohiya NK
Contraception; 1997 Oct; 56(4):251-6. PubMed ID: 9408707
[TBL] [Abstract][Full Text] [Related]
12. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
14. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study.
Coutinho EM; Athayde C; Atta G; Gu ZP; Chen ZW; Sang GW; Emuveyan E; Adekunle AO; Mati J; Otubu J; Reidenberg MM; Segal SJ
Contraception; 2000 Jan; 61(1):61-7. PubMed ID: 10745071
[TBL] [Abstract][Full Text] [Related]
15. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
16. Use of low-dosage oral cyproterone acetate as a male contraceptive.
Wang C; Yeung KK
Contraception; 1980 Mar; 21(3):245-72. PubMed ID: 6771091
[TBL] [Abstract][Full Text] [Related]
17. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
Knuth UA; Yeung CH; Nieschlag E
Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
[TBL] [Abstract][Full Text] [Related]
18. Suppression of human spermatogenesis by testosterone implants.
Handelsman DJ; Conway AJ; Boylan LM
J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
[TBL] [Abstract][Full Text] [Related]
19. Recovery of sperm production following the cessation of gossypol treatment: a two-centre study in China.
Meng GD; Zhu JC; Chen ZW; Wong LT; Zhang GY; Hu YZ; Ding JH; Wang XH; Qian SZ; Wang C
Int J Androl; 1988 Feb; 11(1):1-11. PubMed ID: 3356480
[TBL] [Abstract][Full Text] [Related]
20. Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive.
Brenner PF; Mishell DR; Bernstein GS; Ortiz A
Contraception; 1977 Jun; 15(6):679-91. PubMed ID: 891194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
